ArticleAntimicrobial agents and chemotherapy2022

Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.

Lee-Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.